David S Shames

7PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 03, 2025
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.

Tianshi Lu, Habib Hamidi, Mark A Socinski

|Feb 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

|Sep 13, 2023
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer.

Bruna Pellini, Russell W Madison, Merrida A Childress

|Mar 17, 2023
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer.

Zoe June F Assaf, Wei Zou, Alexander D Fine

Pageof 2

Frequent Collaborators

5 joint publications

Barzin Y Nabet

4 joint publications

Namrata S Patil

4 joint publications

Antoine Italiano

4 joint publications

Delvys Rodriguez Abreu